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In the presence of 2-4 pg tunicamycin/ml, yeast cells stop growth after the cell number has increased 1.5% 
1.7-fold. The cells are arrested in Gl: the rate of DNA synthesis greatly decreases and the budding index 
drops from 0.6 to 0. I. RNA synthesis is inhibited concomitantly, whereas protein synthesis is little affected. 
It is postulated that for Gl/S phase transition to occur one or more proteins have to be glycosylated. 
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1. INTRODUCTION 
The dolichol pathway for N-glycosylation has 
been shown to proceed in all eucaryotic cells [l-6]. 
Since the individual reactions of this pathway have 
been preserved during evolution in a very con- 
servative way, protein glycosylation must be of 
fundamental importance for unicellular as well as 
for multicellular organisms. It is striking, therefore, 
that so little is known about the functions of car- 
bohydrate sidechains on proteins. Evidence has 
been obtained that in some cases they are signals 
for endocytosis [7]. The suggestion that one of 
these signals, the mannosyld-phosphate residue, 
targets lysosomal proteins directly into their organ- 
elle seems questionable, however. Thus, this pos- 
sibility has been ruled out for yeast cells [8] and is 
also doubtful at least for certain human tissues 
[9,10]. A role of glycoproteins in various cell-cell 
interactions has often been invoked. The evidence 
indicating that indeed the glyco-part is required 
for such interactions, is not abundant and in addi- 
tion, for being a general principle, unicellular or- 
ganisms would remain a problem. 
carbon source being sucrose or glucose [14], the 
antibiotic obviously effects a more general reaction 
essential for proliferation. 
An analysis of S. cerevisiae growth inhibition by 
low concentrations of tunicamycin will be reported 
here. It will be shown that cells are specifically 
blocked in the cell cycle in the Gl stage. N-Glyco- 
sylation of protein(s), therefore, is postulated to be 
required for the G 1 /S transition. 
2. MATERIALS AND METHODS 
The haploid S. cerevisiae strain X2180-1A was 
used in this study. The cells were grown in a de- 
lined medium containing 2% glucose [ 151. Tunica- 
mycin has been obtained from Sigma. [2-t4C]Ura- 
cil and [ t Wlphenylalanine plus [6-3Hluracil were 
obtained from NEN (Dreieich) and from 
Amersham-Buchler (Braunschweig), respectively; 
a-factor from Bachem (Basel). 
RNA and DNA synthesis was measured as in 
[16]; protein synthesis was followed by measuring 
[t‘W]phenylalanine incorporation into trichloro- 
acetic acid-insoluble material. 
As most glycosylated enzymes external invertase 
of Saccharomyces cerevisiae does not need its car- 
bohydrate moiety to be active [ 111. However, se- 
cretion of the protein is prevented somehow when 
glycosylation is inhibited by tunicamycin [ 12,131. 
Since logarithmic growth of yeast cells is stopped 
after a while in tunicamycin, independent of the 
Cell number was determined in a Coulter coun- 
ter, absorbance measured in an Eppendorf at 
578 nm and the budding index (number of cells 
budding divided by number of total cells counted) 
was determined microscopically. The cells were 
sonitied before 
bath. 
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3. RESULTS AND DISCUSSION 
Tunicamycin prevents the first reaction of the 
dolichol pathway [ 17-191 and thus N-glycosyla- 
tion of proteins. In the presence of tunicamycin a 
peculiar growth inhibition of logarithmically- 
growing yeast cells is observed (fig. l),which is typi- 
cal for a cell cycle-specific growth stop [20]. The 
increase of cell number and absorbance is slightly 
inhibited for about 1 generation time (- 2.5 h) and 
from then on a strong inhibition is observed; the 
increase in cell number even stops completely. 
After tunicamycin addition cell number generally 
stops after an increase of 1.5%1.7-fold. The in- 
crease in absorbance without a concomitant in- 
crease in cell number is due to an increase in cell 
size and indicates that protein synthesis is less af- 
fected in the presence of tunicamycin (see below). 
These results were obtained in the presence of 2- 
10 pg tunicamycin/ml at -6 x 106 cells/ml. 
The cell cycle in yeast cells can be easily fol- 
lowed since the emergence of the bud giving rise to 
the new daughter cell coincides closely with the 
beginning of the S phase; progress of the cycle 
from there on is reflected in the size of the bud 
[20]. The budding index of the culture after the 
addition of tunicamycin rapidly dropped from 
>0.6 to - 0.15 (tig.2). Tunicamycin obviously 
causes a first cycle stop in G 1. Thus all cells which 
have either initiated S phase when tunicamycin is 
added or cells in G2 and M stage (altogether 60- 
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Fig.1. Growth of S. cerevisiae in the presence and ab- 
sence of tunicamycin. Cells were grown at 30°C as in 
section 2. Tunicamycin (40 pg) was added at time 0 to 
one sample (10 ml). 
70%) are able to Gnish the sequence of events until 
Gl, but are no longer able to start a new S phase. 
This explains the increase in cell number by a fac- 
tor of 1.5-1.7. 
If the above interpretation were correct the rate 
of DNA synthesis should greatly decrease after a 
time interval required to finish S phase, i.e., after 
-40-60 min. Since the test for DNA synthesis 
was not accurate enough to determine this time 
interval precisely the inhibitory effect of tunica- 
mycin on DNA synthesis was compared with that 
caused by (Y factor. The (Y mating factor is known 
to prevent initiation of chromosomal DNA syn- 
thesis in haploid S. cerevisiae of mating type a (2 11. 
Tunicamycin strongly inhibits DNA synthesis 
(tig.3A); time dependence of the effect is within 
experimental error not distinguishable from the in- 
hibition by (Y factor; residual DNA synthesis in (Y 
factor-treated cells corresponds to mitochondrial 
DNA [22]. Tunicamycin also stops net RNA syn- 
thesis after about one generation time (tig.3B), 
which indicates that at least ribosomal RNA is not 
synthesized in G 1 phase enforced by tunicamycin. 
The increase in absorbance without change in 
cell number (tig.1) is due to a continued synthesis 
of protein. Tunicamycin does not inhibit the incor- 
poration of [14C]phenylalanine into protein within 
the first 3 h (fig.3C). In addition the rate stays con- 
stant thereafter for another 3 h. In the control the 
rate increases since the number of ribosomes and 
number of cells increase. Thus, tunicamycin pre- 
vents an increase in the rate of protein synthesis of 
the culture but does not seem to significantly in- 
hibit ongoing protein synthesis. The latter phe- 
nomenon has generally been observed with tunica- 
mycin [ 13,23,24]. 
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Fig.2. Decrease in the number of budding cells in the 
presence of tunicamycin (2 pg/ml). Budding index = 
budding cells/total cells. 
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Fig.3. Effect of tunicamycin on DNA, RNA and protein synthesis. (A) DNA synthesis: 60 ml cells (5 x 106/ml) were 
incubated at 30°C with 225 @Zi [6-3H]uracil (62.5 Ci/mol). After 3 h, two aliquots were removed and tunicamycin 3 pg/ 
ml (0) and (Y factor 10 pg/ml (A) were added, respectively; control without any additions (0). Aliquots of 1 ml were 
analyzed for radioactive DNA as in section 2. (B) RNA synthesis: 10 ml cells (3 x 106/ml) were incubated at 30°C 
(with 10 &i [2-t4C]uracil (3.1 Ci/mol). Aliquots of 0.1 ml were analyzed for radioactive RNA as in section 2; control 
(A); tunicamycin 2 @ml (A). (C) Protein synthesis: 10 ml cells (7 x 106/ml) were incubated with 2 PCi [ t4C]phenylala- 
nine (2 mCi/mol) at 30°C. Aliquots (0.5 ml) were analyzed for radioactive trichloroacetic acid-precipitable material. 
Time, h 
Fig.4. (A,B) Effect of tunicamycin on (Y factor-treated cells: (A) DNA synthesis: control without any (Y factor (0); a 
factor (10 pg/ml) present from O-3 h (A); (Y factor after 3 h replaced by tunicamycin 3 pg/ml (A). Other conditions as in 
fig.3 except that 30 &i [6-3H]uracil (30 Ci/mol) have been used in 10 ml total vol. (B) Budding index after addition and 
removal (arrow) of (Y factor (A); (Y factor replaced by tunicamycin (A). (C) Effect of (Y factor on tunicamycin-treated cells. 
DNA synthesis: control without any tunicamycin (0); tunicamycin present from O-3 h (A); tunicamycin after 3 h 
replaced by (Y factor (A). Other conditions were as in (A) except that in the 2 samples after removal of tunicamycin 
30 $i [6-3H]uracil (120 Ci/mol) have been used. 
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Since tunicamycin seems to prevent the G l/S 
phase transition stationary yeast cells which are in 
Gl [20] should not start growth in the presence of 
tunicamycin. This is indeed the case: when cells of 
an A > 14 were diluted and resuspended in fresh 
medium, they started growth after a lag time of 
2-3 h. In the presence of 3 pg tunicamycin/ml 
neither an increase in budding index nor in cell 
number could be observed (not shown); solely the 
absorbance increased slightly. The same is true for 
cells treated with (Y factor and then transferred to 
new medium. In the presence of tunicamycin 
neither budding nor DNA synthesis starts 
(fig.4A,B). Therefore, the cell cycle block caused 
by tunicamycin either follows the (Y factor block or 
they both affect the cycle at the same site. To dis- 
tinguish between the 2 possibilities cells treated for 
3 h with tunicamycin were subsequently trans- 
ferred to fresh medium with (Y factor. The tunica- 
mycin inhibition is not easily reversible and it 
takes > 5 h before DNA is synthesized again in the 
control (lig.4C). In the presence of (Y factor DNA 
synthesis, however, is not initiated at all. There- 
fore, OL factor and tunicamycin seem to affect the 
cell cycle at the same site or at least sites very 
close to each other; however, their effects are not 
identical. Thus tunicamycin does not induce 
‘shmoos’, the typical cell shape obtained with (Y 
factor, and (Y factor treatment, on the other hand, 
does not inhibit RNA synthesis [25]. 
The results obtained indicate that one or more 
proteins have to be glycosylated so that a yeast cell 
traverses the Gl phase and starts DNA and pro- 
ceeds with rRNA synthesis. A very special feature 
of inhibition by tunicamycin therefore is that it 
synchronizes yeast cells in Gl of the cell cycle. 
Tunicamycin also synchronizes Burkitt lymphoma 
cells; their growth is stopped in G 1, too [26]. These 
results were discussed as an inhibition of the for- 
mation of glycosylated receptors for growth fac- 
tors. Growth factors and their interactions with 
corresponding receptors are required in mam- 
malian cells for Gl /S transition. However, these 
results make it likely that the phenomenon is a 
more general one; it might be related to the ubiq- 
uitous occurrence of protein N-glycosylation in all 
eucaryotic cells. 
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